Uterine evacuation by vaginal misoprostol after second trimester pregnancy interruption

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 3, 1996, Pages 270-273

  Bugalho, Antonio ^a   Bique, Cassimo ^a   Pereira, Caetano ^a   Granja, Ana Carla ^a   Bergström, Staffan ^b,c,d  

^a MAPUTO CENTRAL HOSPITAL   (Mozambique)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF OSLO   (Norway)

^d Department of International Health ^*  (Norway)

Author keywords

Abortion; Methylergometrine; Misoprostol

Indexed keywords

METHYLERGOMETRINE; MISOPROSTOL; PROSTAGLANDIN; UTEROTONIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CURETTAGE; FEMALE; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; UTERUS BLEEDING; UTERUS CAVITY; VOMITING;

EID: 0029928135     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609047100     Document Type: Article

References (16)

1. Royston E, Armstrong S. Preventing maternal deaths. Geneva WHO, 1989.
2. Rodger MW, Beard DD. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary. Lancet 1987; ii: 1415-8.
3. UK multicentre trial: The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. Br J Obstet Gynecol 1990; 97: 480-6.
4. Bugalho A, Bique C, Almeida L, Bergström S. Pregnancy interruption by vaginal misoprostol. Gynecol Obstet Invest 1993; 34: 226-9.
5. Bugalho A, Bique C, Almeida L, Bergström S. Application of vaginal misoprostol prior to cervical dilatation to facilitate pregnancy interruption. A randomized, placebo-controlled study. Obstet Gynecol 1994; 83: 729-31.
6. Schönhöfer PS. Misuse of misoprostol as an abortifacient may induce malformation. Lancet 1991; 337: 1534-5.
7. Arilha M, Barbosa RM. Cytotec in Brazil: 'At least it doesn't kill'. Reprod Health Matters 1993; 2: 41-52.
8. 1 methyl analogue misoprostol on the pregnant human uterus in the first trimester. Geburtsh Frauenheilk 1987; 47: 324-31.
9. 1. Prensa Med Arg 1991; 78: 9-13.
10. Margulies M, Campos Perez GA, Voto LS. Misoprostol to induce labour. Lancet 1992; 339: 64.
11. Sanchez-Ramos L, Kaunitz AM, Del Valle GO, Delke I, Schroeder PA, Briones DK. Labour induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: A randomized trial. Obstet Gynecol 1993; 81: 332-6.
12. Bugalho A, Bique C, Machungo F, Bergström S. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour. Gynecol Obstet Invest 1995; 74: 194-8.
13. Bugalho A, Bique C, Machungo F, Bergström S. Vaginal misoprostol for induction of labor in women with late fetal death. Acta Obstet Gynecol Scand 1995; 39: 252-6.
14. Kotsonis FN, Dodd DC, Regnier B, Kohn FE. Preclinical toxicology profile of misoprostol. Dig Dis Sci 1985; 30 (Suppl 11): 142S-6S.
15. Baird DT, Norman JE, Thong KI, Glasier AF. Misoprostol, mifepristone and abortion, Lancet 1992; 339: 313.
16. Norman JE, Thong KI, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991; 338: 1233-6.